Rachel A. Woolaver

437 total citations
12 papers, 317 citations indexed

About

Rachel A. Woolaver is a scholar working on Immunology, Oncology and Cancer Research. According to data from OpenAlex, Rachel A. Woolaver has authored 12 papers receiving a total of 317 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Immunology, 9 papers in Oncology and 2 papers in Cancer Research. Recurrent topics in Rachel A. Woolaver's work include Immune Cell Function and Interaction (7 papers), Cancer Immunotherapy and Biomarkers (7 papers) and CAR-T cell therapy research (3 papers). Rachel A. Woolaver is often cited by papers focused on Immune Cell Function and Interaction (7 papers), Cancer Immunotherapy and Biomarkers (7 papers) and CAR-T cell therapy research (3 papers). Rachel A. Woolaver collaborates with scholars based in United States and Germany. Rachel A. Woolaver's co-authors include Jing Wang, Zhangguo Chen, Samantha M. Y. Chen, Xiao‐Jing Wang, Dexiang Gao, Antonio Jimeno, Xiaoguang Wang, Christian D. Young, David Raben and Yan Lan and has published in prestigious journals such as The Journal of Immunology, International Journal of Molecular Sciences and Frontiers in Immunology.

In The Last Decade

Rachel A. Woolaver

12 papers receiving 316 citations

Peers

Rachel A. Woolaver
Tugs‐Saikhan Chimed United States
Marice Alcantara United States
Ioana Plesca Germany
Lucas Blanchard United States
Tugs‐Saikhan Chimed United States
Rachel A. Woolaver
Citations per year, relative to Rachel A. Woolaver Rachel A. Woolaver (= 1×) peers Tugs‐Saikhan Chimed

Countries citing papers authored by Rachel A. Woolaver

Since Specialization
Citations

This map shows the geographic impact of Rachel A. Woolaver's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Rachel A. Woolaver with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Rachel A. Woolaver more than expected).

Fields of papers citing papers by Rachel A. Woolaver

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Rachel A. Woolaver. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Rachel A. Woolaver. The network helps show where Rachel A. Woolaver may publish in the future.

Co-authorship network of co-authors of Rachel A. Woolaver

This figure shows the co-authorship network connecting the top 25 collaborators of Rachel A. Woolaver. A scholar is included among the top collaborators of Rachel A. Woolaver based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Rachel A. Woolaver. Rachel A. Woolaver is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

12 of 12 papers shown
1.
Woolaver, Rachel A., et al.. (2023). Host-specific differences in top-expanded TCR clonotypes correlate with divergent outcomes of anti-PD-L1 treatment in responders versus non-responders. Frontiers in Immunology. 14. 1100520–1100520. 1 indexed citations
3.
Chen, Samantha M. Y., Rachel A. Woolaver, Etienne Danis, et al.. (2022). Differential responses to immune checkpoint inhibitor dictated by pre-existing differential immune profiles in squamous cell carcinomas caused by same initial oncogenic drivers. Journal of Experimental & Clinical Cancer Research. 41(1). 123–123. 14 indexed citations
4.
Dyjack, Nathan, S. Harsha Krovi, Cydney Rios, et al.. (2021). Single cell analysis of host response to helminth infection reveals the clonal breadth, heterogeneity, and tissue-specific programming of the responding CD4+ T cell repertoire. PLoS Pathogens. 17(6). e1009602–e1009602. 9 indexed citations
5.
Woolaver, Rachel A., Christian D. Young, Sana D. Karam, et al.. (2021). Distinct immune microenvironment profiles of therapeutic responders emerge in combined TGFβ/PD-L1 blockade-treated squamous cell carcinoma. Communications Biology. 4(1). 1005–1005. 18 indexed citations
6.
Woolaver, Rachel A., Xiaoguang Wang, Samantha M. Y. Chen, et al.. (2021). Differences in TCR repertoire and T cell activation underlie the divergent outcomes of antitumor immune responses in tumor-eradicating versus tumor-progressing hosts. Journal for ImmunoTherapy of Cancer. 9(1). e001615–e001615. 25 indexed citations
7.
Chen, Zhangguo, et al.. (2020). TRAF3 Acts as a Checkpoint of B Cell Receptor Signaling to Control Antibody Class Switch Recombination and Anergy. The Journal of Immunology. 205(3). 830–841. 17 indexed citations
8.
Woolaver, Rachel A., et al.. (2020). MHC class I-independent activation of virtual memory CD8 T cells induced by chemotherapeutic agent-treated cancer cells. Cellular and Molecular Immunology. 18(3). 723–734. 26 indexed citations
9.
Chen, Samantha M. Y., Li Bian, Tonya M. Brunetti, et al.. (2020). Deletion of p53 and Hyper-Activation of PIK3CA in Keratin-15+ Stem Cells Lead to the Development of Spontaneous Squamous Cell Carcinoma. International Journal of Molecular Sciences. 21(18). 6585–6585. 11 indexed citations
10.
Woolaver, Rachel A., et al.. (2020). HDAC inhibitors overcome immunotherapy resistance in B-cell lymphoma. Protein & Cell. 11(7). 472–482. 73 indexed citations
11.
Chen, Samantha M. Y., et al.. (2020). Tumor immune microenvironment in head and neck cancers. Molecular Carcinogenesis. 59(7). 766–774. 116 indexed citations
12.
Woolaver, Rachel A., et al.. (2018). Library Preparation for ATAC-Sequencing of Mouse CD4+ T Cells Isolated from the Lung and Lymph Nodes After Helminth Infection. Methods in molecular biology. 1799. 327–340. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026